SMURF1 Amplification in Pancreatic Cancer
Author Information
Author(s): Kwei Kevin A., Shain A. Hunter, Bair Ryan, Montgomery Kelli, Karikari Collins A., van de Rijn Matt, Hidalgo Manuel, Maitra Anirban, Bashyam Murali D., Pollack Jonathan R.
Primary Institution: Stanford University
Hypothesis
Does SMURF1 amplification promote invasiveness in pancreatic cancer?
Conclusion
SMURF1 amplification drives cell invasiveness and anchorage-independent growth in pancreatic cancer.
Supporting Evidence
- SMURF1 was confirmed to be amplified in 4.2% of primary pancreatic cancer cases.
- Knockdown of SMURF1 reduced cell invasion in pancreatic cancer cell lines.
- Overexpression of SMURF1 led to loss of contact inhibition in fibroblast cells.
Takeaway
The study found that a gene called SMURF1 is more common in pancreatic cancer and helps the cancer cells grow and spread.
Methodology
High-resolution genomic profiling and RNA interference were used to study SMURF1 in pancreatic cancer cell lines and xenografts.
Limitations
The study primarily focused on a single cell line with SMURF1 amplification, which may limit the generalizability of the findings.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website